St. Jude Medical (STJ) Tops Q1 EPS by 3c; Guides Q2, FY12

St. Jude Medical, Inc. (NYSE: STJ) reported Q1 EPS of $0.86, $0.03 better than the analyst estimate of $0.83. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.38 billion.

Sees Q2 2012 EPS of $0.86-$0.88, versus the consensus of $0.89.

St. Jude Medical, Inc. sees FY2012 EPS of $3.44-$3.49, versus the consensus of $3.46.

For earnings history and earnings-related data on St. Jude Medical, Inc. (STJ) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Reading (RDI) Tops Q2 EPS by 4c